HopeStage
Back to all studies
TerminatedNCT02479906

A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of PTSD (PTSD)

This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with PTSD.

Device studyAges 22–68Multiple countries
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with PTSD.

Who could participate?

This study is for people with PTSD. Listed age limits: 22 years to 68 years. Other eligibility criteria apply.

Listed locations
Los Angeles and 14 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 17, 2016
Recruitment status
Terminated
Enrollment listed in the registry
203
Sponsor
Brainsway
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States, Canada, Israel
Age range
From 22 Years to 68 Years
Official registry ID
NCT02479906
Official title
Show the full official title

A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-Traumatic Stress Disorder (PTSD)

Recruitment & locations

Terminated

Los Angeles, United States · Palo Alto, United States · San Diego, United States

11 more locations
  • Gainesville, United States
  • Juno Beach, United States
  • Palm Beach, United States
  • Royal Palm Beach, United States
  • Evanston, United States
  • New York, United States
  • Raleigh, United States
  • Charleston, United States
  • Toronto, Canada
  • Be’er Ya‘aqov, Israel
  • Tel HaShomer, Israel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with PTSD.

Who is behind this study?

The study sponsor is Brainsway.

Who can participate?

This study is for people with PTSD. Listed age limits: 22 years to 68 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies